IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Blue JAY Capital Management, LLC

Q2 2016 Holdings

Filed 2016-08-12 | 14 holdings | $32.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COMMON STOCKS09061G101$11.8M152,25336.3%
Boston Scientific Corp(BSX)COMMON STOCKS101137107$11.0M469,90033.7%
Biogen Inc(BIIB)COMMON STOCKS09062X103$9.7M40,00029.7%
Neurocrine Biosciences Inc(NBIX)COMMON STOCKS64125C109$13.9K305,6300.0%
Seattle Genetics IncCOMMON STOCKS812578102$13.3K328,4300.0%
Mead Johnson Nutrition CoCOMMON STOCKS582839106$12.3K135,0450.0%
Masimo Corp(MASI)COMMON STOCKS574795100$11.5K218,9600.0%
Abiomed Inc(ABMDEUR)COMMON STOCKS003654100$11.5K104,9200.0%
Vertex Pharmaceuticals Inc(VRTX)COMMON STOCKS92532F100$10.8K125,4500.0%
Ironwood Pharmaceuticals Inc(IRWD)COMMON STOCKS46333X108$10.7K821,0700.0%
Molina Healthcare Inc(MOH)COMMON STOCKS60855R100$10.2K205,2700.0%
Nuvasive Inc(NUVAGBP)COMMON STOCKS670704105$9.5K159,6600.0%
Allergan PLCCOMMON STOCKSG0177J108$8.5K36,9400.0%
Shire PLCCOMMON STOCKS82481R106$7.6K41,0600.0%